Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 9, 2022
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immucell Corp /de/
|
0
|
—
|
—
|
—
|
0
|
Jan 31
| |||||||
Immucell Corp /de/
| 47.5K |
$1.70 | $80,750.00 | +30.21% | 204.75K |
Dec 28
| |||||||
Immucell Corp /de/
|
0
|
—
|
—
|
—
|
0
|
Jan 8
| |||||||
Immucell Corp /de/
| 1K |
$5.25 | $5,250.00 | +0.64% | 157.25K |
Mar 17
| |||||||
Immucell Corp /de/
|
0
|
—
|
—
|
—
|
0
|
Feb 10
| |||||||
Immucell Corp /de/
| 1K |
$3.10 | $3,100.00 | +0.64% | 156.25K |
Dec 13
| |||||||
Immucell Corp /de/
| 382 |
$4.19 | $4.94 | +0.25% | 155.25K |
Nov 16
| |||||||
Immucell Corp /de/
| 1K |
$2.00 | $2,000.00 | +0.65% | 154.87K |
Dec 10
| |||||||
Immucell Corp /de/
| 51K |
$1.31 | $66,937.50 | +49.58% | 153.87K |
Feb 27
| |||||||
Immucell Corp /de/
|
0
|
—
|
—
|
—
|
0
|
Jan 9
| |||||||
Immucell Corp /de/
| 388 |
$3.27 | $1,268.76 | +0.38% | 102.87K |
Jan 2
| |||||||
Immucell Corp /de/
| 612 |
$3.27 | $2,001.24 | +0.60% | 102.48K |
Dec 19
| |||||||
Immucell Corp /de/
| 500 |
$3.74 | $1,870.00 | +0.49% | 101.87K |
Sep 5
| |||||||
Immucell Corp /de/
|
0
|
—
|
—
|
—
|
0
|
Mar 19
| |||||||
Immucell Corp /de/
| 5.09K |
$5.48 | $3.30 | +5.29% | 101.37K |
Mar 28
| |||||||
Immucell Corp /de/
| 500 |
$1.69 | $843.75 | +0.52% | 96.28K |
Dec 7
| |||||||
Immucell Corp /de/
| 10.5K |
$1.94 | $20,343.75 | +12.31% | 95.78K |
Jun 6
| |||||||
Immucell Corp /de/
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||